In today’s podcasts, Dr. Blevins talks about the genesis of pseudo Cushing’s syndrome and illustrates a fascinating case of pseudo Cushing’s syndrome due to alcohol ingestion.
What does medical decision-making mean, and what is involved? What are pituitary specialists thinking about when faced with decisions on how to treat a patient? This live talk session aims at answering these tough questions. Dr. Blevins walks us through the case of a patient with high cortisol to illustrate the types of decisions physicians make and what those decisions are based on when trying to solve a medical mystery to best help patients. This podcast will shed some light on what a physician does when making medical decisions. Enjoy!
In this book, a group of leading world-renowned clinicians and editors, Dr. Manish Aghi and Dr. Lewis Blevins, give us a guide to medical decision-making on diagnosing and treating patients with acromegaly. The goal of this publication was to construct a book that was different from any other on acromegaly.
Acroline™ is a series of four brochures created by Pfizer in collaboration with an international panel of people with acromegaly, acromegaly support groups, and health psychologists. This series of supportive guides and tools are designed to help keep your life on track and live well with acromegaly.
In this podcast from our “musings series” comes an interesting discussion on lab result targets. This case comes from a hypothyroid patient who wanted to achieve a particular TSH lab result target. In the discussion, Dr. Blevins focuses on how the pituitary works, how lab tests work, and what makes aiming at and achieving a narrow target almost impossible.
The Spanish Association of Endocrinology and Nutrition held its 63rd annual congress this October 26 to 29. The Spanish association SEEN (Sociedad Española de Endocrinología y Nutricíon) presented an excellent agenda, including the latest endocrine
We take advantage of Acromegaly Day, coming up on November 1, to highlight resources from industry partners. The Pfizer Patient Affairs Liaisons (PALs) connect patients and caregivers affected by rare conditions with programs and information. PALs work with
Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.
Do you ever wonder what happens in the OR after you are wheeled in? We welcome once again our friend and contributor, Manish Aghi, M.D. Ph.D., Attending Neurosurgeon at the California Center for Pituitary Disorders, Professor of Neurological Surgery, and Principal Investigator at UCSF Brain Tumor Research Center. He spent an amazing hour with Dr. Blevins and me, walking us through his work with patients before surgery, his approaches post-surgery, recovery, potential issues, and the many other phases of pituitary surgery.
To continue our focus on pituitary awareness month, this session touches on various issues related to awareness and its importance as a critical factor in reducing the time to diagnosis.
We want your thoughts and opinions on our LIVE-TALK program, your preferences for times and days, other subjects we should cover, and any other issues you’d like us to consider to ensure the program reflects your insights.
From the editors: In what is now a yearly occurrence, pituitary groups and industry from all over the world mark October as pituitary awareness month. “The hope in doing this work is to organize a joint effort to maximize the opportunity to talk with a unified voice and increase awareness of pituitary diseases,” said JD Faccinetti, Chairman and chief editor of Pituitary World News.